Ticker
NUVL
Analysis
Nuvalent, Inc. (NUVL) Stock Analysis
Nuvalent, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to NUVL.
Nuvalent, Inc.
Nuvalent, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to NUVL.
Stock profile
Asset type
Stock
Market cap
$9.75B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Currency
USD
Ticker listings
Nuvalent, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- NUVL primary listing
Latest Nuvalent, Inc. news
Deerfield Management Announces Portfolio Company Nuvalent, Inc. to be Acquired by GSK
Deerfield Management, an investment firm dedicated to advancing healthcare, today announced that portfolio company Nuvalent, Inc. has entered into a definitive agreement to be a...
Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVL
Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. -
Nuvalent Announces Key Program and Business Updates, Strengthening Foundation for Global Leadership in ROS1- and ALK-positive NSCLC
Nuvalent Announces Key Program and Business Updates, Strengthening Foundation for Global Leadership in ROS1- and ALK-positive NSCLC
Nuvalent Highlights Upcoming Data Presentations for Neladalkib and Zidesamtinib at the 2026 American Society of Clinical Oncology Annual ...
Nuvalent Highlights Upcoming Data Presentations for Neladalkib and Zidesamtinib at the 2026 American Society of Clinical Oncology Annual
Nuvalent Highlights Recent Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2026 Financial Results
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today ...
Research sections
Valuation
Review valuation context for Nuvalent, Inc..
Future growth
Review future growth context for Nuvalent, Inc..
Past performance
Review past performance context for Nuvalent, Inc..
Financial health
Review financial health context for Nuvalent, Inc..
Dividend
Review dividend context for Nuvalent, Inc..
Management
Review management context for Nuvalent, Inc..
Ownership
Review ownership context for Nuvalent, Inc..
Other information
Review other information context for Nuvalent, Inc..
Community
Review community context for Nuvalent, Inc..